Biblio
Alemtuzumab, dual GVHD prophylaxis, and lower CD3+ T cell doses equalize rates of acute and chronic GVHD among pediatric patients receiving allogeneic HSCT with matched unrelated donor PBSC or bone marrow grafts. Transplant Cell Ther. 2023.
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL. J Clin Oncol. 2023:JCO2301392.
High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial GATA2 deficiency. Cancer Genet. 2021;256-257:77-80.
Burden of adenoviraemia predicts survival in paediatric recipients of allogeneic haematopoietic stem cell transplant. J Clin Virol. 2020;127:104373.
.